Regorafenib is a potent multi-kinase inhibitor. It affects MAPK signaling pathways, by blocking RTKs, to inhibit tumor growth.
Regorafenib (BAY 73-4506) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Regorafenib (BAY 73-4506) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.